Kaplan S - Search Results

1

A randomized comparison of doxifluridine and fluorouracil in colorectal carcinoma.

Alberto P, Mermillod B, Germano G, Kaplan S, Weber W, Joss R, Spati B, Martz G, Cavalli F. Alberto P, et al. Among authors: kaplan s. Eur J Cancer Clin Oncol. 1988 Mar;24(3):559-63. doi: 10.1016/s0277-5379(98)90037-2. Eur J Cancer Clin Oncol. 1988. PMID: 2968263 Clinical Trial.

2

Etoposide, cisplatin and doxorubicin in patients with small cell lung cancer: tumor response and long term survival.

Alberto P, Mermillod B, Joss R, Obrecht JP, Martz G, Kaplan S, Cavalli F. Alberto P, et al. Among authors: kaplan s. Eur J Cancer Clin Oncol. 1986 Jun;22(6):701-8. doi: 10.1016/0277-5379(86)90169-0. Eur J Cancer Clin Oncol. 1986. PMID: 3017722

3

Phase II study of doxifluridine in advanced colorectal adenocarcinoma.

Abele R, Alberto P, Kaplan S, Siegenthaler P, Hofmann V, Ryssel HJ, Hartmann D, Holdener EE, Cavalli F. Abele R, et al. Among authors: kaplan s. J Clin Oncol. 1983 Dec;1(12):750-4. doi: 10.1200/JCO.1983.1.12.750. J Clin Oncol. 1983. PMID: 6230419

4

A phase I trial of marcellomycin with a weekly dose schedule.

Joss RA, Kaplan S, Goldhirsch A, Varini M, Brunner KW, Cavalli F. Joss RA, et al. Among authors: kaplan s. Eur J Cancer Clin Oncol. 1983 Apr;19(4):455-9. doi: 10.1016/0277-5379(83)90106-2. Eur J Cancer Clin Oncol. 1983. PMID: 6683183

5

Phase I trial of 1,2,4-triglycidylurazol (TGU, NSC 332488): a new triepoxide cytostatic agent.

Hansen SW, Bach F, Hansen HH, Kaplan S, Cavalli F. Hansen SW, et al. Among authors: kaplan s. Eur J Cancer Clin Oncol. 1985 Mar;21(3):301-5. doi: 10.1016/0277-5379(85)90129-4. Eur J Cancer Clin Oncol. 1985. PMID: 4007009

6

Phase I trial of 4-demethoxydaunorubicin with single i.v. doses.

Kaplan S, Martini A, Varini M, Togni P, Cavalli F. Kaplan S, et al. Eur J Cancer Clin Oncol. 1982 Dec;18(12):1303-6. doi: 10.1016/0277-5379(82)90133-x. Eur J Cancer Clin Oncol. 1982. PMID: 6962779

7

Phase-II study with cis-dichlorodiammineplatinum (II) in small cell anaplastic bronchogenic carcinoma.

Cavalli F, Goldhirsch A, Siegenthaler P, Kaplan S, Beer M. Cavalli F, et al. Among authors: kaplan s. Eur J Cancer (1965). 1980 May;16(5):617-21. doi: 10.1016/0014-2964(80)90201-7. Eur J Cancer (1965). 1980. PMID: 6993212 Clinical Trial. No abstract available.

8

A phase I trial of cis-diammine-1,1-cyclobutane dicarboxylate platinum II (Carboplatin, CBDCA, JM-8) with a single dose every five week-schedule.

Joss RA, Kaplan S, Goldhirsch A, Sessa C, Brunner KW, Cavalli F. Joss RA, et al. Among authors: kaplan s. Invest New Drugs. 1984;2(3):297-304. doi: 10.1007/BF00175380. Invest New Drugs. 1984. PMID: 6392147

9

[Chemotherapy of non-small-cell bronchial cancer with a combination of Cis-diamminedichloroplatinum (II) and VP 16-213].

Joss R, Goldhirsch A, Cavalli F, Weber W, Kaplan S, Obrecht JP, Sonntag R, Brunner KW. Joss R, et al. Among authors: kaplan s. Schweiz Med Wochenschr. 1981 Sep 5;111(36):1331-4. Schweiz Med Wochenschr. 1981. PMID: 7197802 German.

10

Phase II trial of 4'-deoxydoxorubicin in advanced non-small cell lung cancer.

Kaplan S, Sessa C, Joss R, Obrecht JP, Siegenthaler P, Cavalli F. Kaplan S, et al. Cancer Treat Rep. 1985 Nov;69(11):1337-8. Cancer Treat Rep. 1985. PMID: 4092200 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,011 results

Search Page